The Evolving Landscape of Pharmaceutical Wastewater Management The global pharmaceutical industry is currently navigating a period of significant transition, where environmental compliance has moved ...

The Ohio Division of Cannabis Control (DCC) issued a product recall Friday for certain products made by Marichron Pharma ...

Ascendis Pharma (NASDAQ:ASND) is one of the best NASDAQ growth stocks to buy for the next 2 years. On February 11, Ascendis Pharma reported that it nearly doubled its total revenue for 2025 to €720 ...

Dr. Chase launches “Trust Over Trends” for Family Day, promoting affordable, proven remedies over wellness fads to ...

A key insight from the whitepaper is the increasing divergence in verification expectations between regions. While the EU requires product verification prior to dispensing, the U.S. system relies on ...

Viatris anticipates $500 million in net cost savings by 2028, with reinvestment supporting higher-value brands. Click to read ...

Novartis AG’s exit from its listed Indian subsidiary highlights a growing trend of "Big Pharma" companies divesting from the hyper-competitive Indian market.

GLP-1 therapies are a cornerstone for the management of type 2 diabetes, supporting glycemic control and improving ...

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) is one of the best NASDAQ growth stocks to buy for the next 2 years. On February 12, Alnylam Pharmaceuticals reported its earnings for 2025, with nearly $3 ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. A copy of the ...

President Donald Trump's "reciprocal" tariffs were deemed unconstitutional by the Supreme Court, but some sector-specific tariffs remain in place.